28274612|t|Effects of obesity on IL-33 / ST2 system in heart, adipose tissue and liver: study in the experimental model of Zucker rats
28274612|a|Suppression of tumorigenicity 2 (ST2) mediates the effect of Interleukin-33 (IL-33). Few data are reported on the relationship between IL-33 / ST2 and obesity. We aimed to investigate effects of obesity on IL-33 / ST2 system in heart, adipose tissue and liver in a rodent model of obesity. The relationship of cardiac expression of IL-33 / ST2 system with natriuretic peptides (NPs) system and inflammatory mediators was also studied. mRNA expression of IL-33 / ST2 system was evaluated in cardiac, adipose and hepatic biopsies from obese Zucker rats (O) and controls (CO). Expression levels of sST2 was significantly lower in O rats compared with CO (p<0.05) in all tissues. Besides, the mRNA levels of IL-33 decreased significant in fat of O respect to CO, while, expression levels of ST2L was significantly higher in liver of CO than in O. A strong relationship of IL-33 / ST2 with NPs and classical inflammatory mediators was observed in cardiac tissue. Expression of sST2 in cardiac, adipose and liver tissue decreased in O compared with controls, suggesting an involvement for IL-33 / ST2 system in molecular mechanisms of obesity. The strong relationships with NP systems and inflammatory mediators could suggest an involvement for IL-33 / ST2 in molecular pathways leading to cardiac dysfunction and inflammation associated with obesity.
28274612	11	18	obesity	T038	UMLS:C0028754
28274612	22	27	IL-33	T103	UMLS:C2976122
28274612	30	33	ST2	T103	UMLS:C3849696
28274612	44	49	heart	T017	UMLS:C0018787
28274612	51	65	adipose tissue	T017	UMLS:C0001527
28274612	70	75	liver	T017	UMLS:C0023884
28274612	77	82	study	T062	UMLS:C0008972
28274612	90	108	experimental model	T170	UMLS:C0086272
28274612	112	123	Zucker rats	T204	UMLS:C0034719
28274612	124	155	Suppression of tumorigenicity 2	T103	UMLS:C3849696
28274612	157	160	ST2	T103	UMLS:C3849696
28274612	185	199	Interleukin-33	T103	UMLS:C2976122
28274612	201	206	IL-33	T103	UMLS:C2976122
28274612	259	264	IL-33	T103	UMLS:C2976122
28274612	267	270	ST2	T103	UMLS:C3849696
28274612	275	282	obesity	T038	UMLS:C0028754
28274612	319	326	obesity	T038	UMLS:C0028754
28274612	330	335	IL-33	T103	UMLS:C2976122
28274612	338	341	ST2	T103	UMLS:C3849696
28274612	352	357	heart	T017	UMLS:C0018787
28274612	359	373	adipose tissue	T017	UMLS:C0001527
28274612	378	383	liver	T017	UMLS:C0023884
28274612	389	401	rodent model	T038	UMLS:C1519106
28274612	405	412	obesity	T038	UMLS:C0028754
28274612	434	441	cardiac	T017	UMLS:C1272575
28274612	442	452	expression	T038	UMLS:C1171362
28274612	456	461	IL-33	T103	UMLS:C2976122
28274612	464	467	ST2	T103	UMLS:C3849696
28274612	480	500	natriuretic peptides	T103	UMLS:C1144709
28274612	502	505	NPs	T103	UMLS:C1144709
28274612	518	540	inflammatory mediators	T038	UMLS:C3155540
28274612	559	574	mRNA expression	T038	UMLS:C1515670
28274612	578	583	IL-33	T017	UMLS:C1825595
28274612	586	589	ST2	T017	UMLS:C1420442
28274612	614	621	cardiac	T058	UMLS:C0189784
28274612	623	630	adipose	T017	UMLS:C0001527
28274612	635	651	hepatic biopsies	T058	UMLS:C0193388
28274612	657	674	obese Zucker rats	T204	UMLS:C0034719
28274612	676	677	O	T204	UMLS:C0034719
28274612	698	708	Expression	T038	UMLS:C1171362
28274612	719	723	sST2	T103	UMLS:C3852857
28274612	751	757	O rats	T204	UMLS:C0034719
28274612	791	798	tissues	T017	UMLS:C0040300
28274612	813	817	mRNA	T103	UMLS:C0035696
28274612	828	833	IL-33	T017	UMLS:C1825595
28274612	866	867	O	T204	UMLS:C0034719
28274612	890	900	expression	T038	UMLS:C0017262
28274612	911	915	ST2L	T017	UMLS:C1416400
28274612	944	949	liver	T017	UMLS:C0023884
28274612	964	965	O	T204	UMLS:C0034719
28274612	992	997	IL-33	T103	UMLS:C2976122
28274612	1000	1003	ST2	T103	UMLS:C3849696
28274612	1009	1012	NPs	T103	UMLS:C1144709
28274612	1027	1049	inflammatory mediators	T038	UMLS:C3155540
28274612	1066	1080	cardiac tissue	T017	UMLS:C1272575
28274612	1082	1092	Expression	T038	UMLS:C1171362
28274612	1096	1100	sST2	T103	UMLS:C3852857
28274612	1104	1111	cardiac	T017	UMLS:C1272575
28274612	1113	1120	adipose	T017	UMLS:C0001527
28274612	1125	1137	liver tissue	T017	UMLS:C0023884
28274612	1151	1152	O	T204	UMLS:C0034719
28274612	1207	1212	IL-33	T103	UMLS:C2976122
28274612	1215	1218	ST2	T103	UMLS:C3849696
28274612	1229	1249	molecular mechanisms	T038	UMLS:C1148560
28274612	1253	1260	obesity	T038	UMLS:C0028754
28274612	1292	1294	NP	T103	UMLS:C1144709
28274612	1307	1329	inflammatory mediators	T038	UMLS:C3155540
28274612	1363	1368	IL-33	T103	UMLS:C2976122
28274612	1371	1374	ST2	T103	UMLS:C3849696
28274612	1378	1396	molecular pathways	T038	UMLS:C1704259
28274612	1408	1427	cardiac dysfunction	T033	UMLS:C3277906
28274612	1432	1444	inflammation	T038	UMLS:C0021368
28274612	1461	1468	obesity	T038	UMLS:C0028754